Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients

Pediatric Nephrology

Volumn 26, Issue 7, 2011, Pages 1123-1128

  Silverstein, Douglas M ^a   Srivaths, Poyyapkam R ^b   Mattison, Parnell ^a   Upadhyay, Kiran ^a   Midgley, Laurie ^a   Moudgil, Asha ^a   Goldstein, Stuart L ^c   Feig, Daniel I ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

End stage renal disease; Hypertension; Uric acid

Indexed keywords

ANTIHYPERTENSIVE AGENT; PROTEIN; URIC ACID;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHILD; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPERVOLEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTAKE; RISK ASSESSMENT; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; WEIGHT GAIN;

ADOLESCENT; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY WEIGHT; CHILD; FEMALE; HUMANS; HYPERTENSION; HYPERURICEMIA; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; UP-REGULATION; URIC ACID; YOUNG ADULT;

EID: 80052512905     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1875-0     Document Type: Article

References (36)

1. Davis N (1897) The cardiovascular and renal relations and manifestations of gout. JAMA 29:261-262.
2. Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH (1966) Hyperuricemia in primary and renal hypertension. N Engl J Med 275:457-464.
3. Gertler MM, Garn SM, Levine SA (1951) Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 34:1421-1431.
4. Ford ES, Li C, Cook S, Choi HK (2007) Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115:2526-2532. (Pubitemid 46763226)
5. Tuttle KR, Short RA, Johnson RJ (2001) Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 87:1411-1414. (Pubitemid 32523032)
6. Lehto S, Niskanen L, Rönnemaa T, Laakso M (1998) Serum uric acid is a strong predictor of stroke in patients with non-insulindependent diabetes mellitus. Stroke 29:635-639. (Pubitemid 28145791)
7. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:F991-997. (Pubitemid 34654464)
8. Feig DI, Johnson RJ (2003) Hyperuricemia in childhood primary hypertension. Hypertension 42:247-252. (Pubitemid 37093468)
9. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men. The Osaka Health Survey. J Hypertens 19:1209-1215. (Pubitemid 32595276)
10. Torok E, Gyarfas I, Csukas M (1985) Factors associated with stable high blood pressure in adolescents. J Hypertens Suppl 3 [Suppl 3]:S389-390. (Pubitemid 17200010)
11. Kahn HA, Medalie JH, Neufeld HN, Riss E, Goldbourt U (1972) The incidence of hypertension and associated factors: the Israel ischemic heart study. Am Heart J 84:171-182.
12. Goldstein HS, Manowitz P (1993) Relation between serum uric acid and blood pressure in adolescents. Ann Hum Biol 20:423-431.
13. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, Wofford MR, Herrington DM (2006) Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension 48:1037-1042. (Pubitemid 44772705)
14. Feig DI, Soletsky B, Johnson RJ (2008) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300:924-932.,
15. Kasanen A, Kallio V, Markkanen T (1958) On serum uric acid and endogenic uric acid clearance in renal failure. Acta Med Scand 160:503-507.
16. Goldberg M, Castleman L, Wallace SL (1960) Removal of uric acid by the artificial kidney in patients with acute renal failure. J Lab Clin Med 55:268-273.
17. Firmat J, Vanamee P, Klauber L, Krakoff I, Randall HT (1960) The artificial kidney in the treatment of renal failure and hyperuricemia in patients with lymphoma and leukemia. Cancer 13:276-282.
18. Feig DI (2009) Uric acid: a novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens 18:526-530.
19. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V (2009) Uric acid and long-term outcomes in CKD. Am J Kidney Dis 53:796-803.
20. Tang Z, Cheng LT, Li HY, Wang TI (2009) Serum uric acid and endothelial dysfunction in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 29:368-373.
21. Lee SM, Lee AL, Winters TJ, Tam E, Jaleel M, Stenvinkel P, Johnson RJ (2009) Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol 29:79-85.
22. Hsu SP, Pai MF, Peng YS, Chiang CK, Ho TI, Hung KY (2004) Serum uric acid levels show a 'J-shaped' association with allcause mortality in haemodialysis patients. Nephrol Dial Transplant 19:457-462.
23. Mitsnefes M, Stablein D (2005) Hypertension in pediatric patients on long-term dialysis: a report of the North American pediatric renal transplant cooperative study (NAPRTCS). Am J Kidney Dis 45:309-315. (Pubitemid 40431057)
24. Lingens N, Soergel M, Loirat C, Busch C, Lemmer B, Schärer K (1995) Ambulatory blood pressure monitoring in pediatric patients treated by regular hemodialysis and peritoneal dialysis. Pediatr Nephrol 9:167-172.
25. Holtta T, Happonen JM, Ronnholm K, Fyhrquist F, Holmberg C (2001) Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol 16:324-331. (Pubitemid 32366665)
26. Tkaczyk M, Nowicki M, Balasz-Chmielewska I, Boguszewska- Baçzkowska H, Drozdz D, Kołłataj B, Jarmoliński T, Jobs K, Kiliś-Pstrusińska K, Leszczyńska B, Makulska I, Runowski D, Stankiewicz R, Szczepańska M, Wierciński R, Grenda R, Kanik A, Pietrzyk JA, Roszkowska-Blaim M, Szprynger K, Zachwieja J, Zajaczkowska MM, Zoch-Zwierz W, Zwolińska D, Zurowska A (2006) Hypertension in dialysed children: the prevalence and therapeutic approach in Poland-a nationwide survey. Nephrol Dial Transplant 21:736-742. (Pubitemid 43372923)
27. Van DeVoorde RG, Barletta G, Chand DH, Dresner IG, Lane J, Leiser J, Lin JJ, Pan CG, Patel H, Valentini RP, Mitsnefes MM (2007) Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol 22:547-553. (Pubitemid 46332334)
28. Mitsnefes M, Stablein D (2005) Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 45:309-315. (Pubitemid 40431057)
29. Foundation NK, Initiative The Kidney Disease Outcomes Quality (2006) Clinical Practice Guidelines and Clinical Practice Recommendations. Am J Kidney Dis 48:S2-S97.
30. National high blood pressure education program working group on high blood pressure in children and adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 (2):555-576.
31. Jain SR, Smith L, Brewer ED, Goldstein SL (2001) Non-invasive intravascular monitoring in the pediatric hemodialysis population. Pediatr Nephrol 16:15-18. (Pubitemid 32110990)
32. Michael M, Brewer ED, Goldstein SL (2004) Blood volume monitoring to achieve target weight in pediatric hemodialysis patients. Pediatr Nephrol 19:432-437. (Pubitemid 38477408)
33. Saito I, Saruta T, Kondo K, Nakamura R, Oguro T, Yamagami K, Ozawa Y, Kato E (1978) Serum uric acid and the reninangiotensin system in hypertension. J Am Geriatr Soc 26:241-247. (Pubitemid 8361291)
34. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD (2002) Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106:221-226. (Pubitemid 34761303)
35. Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJS, Anker SD, Hambrecht R (2002) Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure. Circulation 105:2619-2624. (Pubitemid 34596038)
36. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ (2003) Uric acid stimulates MCP-1 production in vascular smooth muscle cells via MAPK and COX-2. Hypertension 41:1287-1293.